EP2981617 - THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/CAS SYSTEMS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.05.2024 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 02.06.2023 | ||
Former | Grant of patent is intended Status updated on 08.11.2022 | ||
Former | Examination is in progress Status updated on 29.01.2021 | ||
Former | Request for examination was made Status updated on 31.01.2020 | Most recent event Tooltip | 02.08.2024 | Lapse of the patent in a contracting state New state(s): SI | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states President and Fellows of Harvard College 17 Quincy Street Cambridge, MA 02138 / US | For all designated states The Children's Medical Center Corporation 55 Shattuck Street Boston, Massachusetts 02115 / US | [2016/52] |
Former [2016/06] | For all designated states President and Fellows of Harvard College 17 Quincy Street Cambridge, MA 02138 / US | ||
For all designated states Children's Medical Center Corporation 55 Shattuck Street Boston, MA 02115 / US | Inventor(s) | 01 /
MUSUNURU, Kiran 60 Brattle Street Apt 206 Cambridge, MA 02138 / US | 02 /
COWAN, Chad, A. 5 Strong Place Boston, MA 02114 / US | 03 /
ROSSI, Derrick, J. 162 Metropolitan Avenue Roslindale, MA 02131 / US | [2016/06] | Representative(s) | Lock, Graham James Fry Heath & Spence LLP Unit A, Faraday Court Faraday Road Crawley, West Sussex RH10 9PU / GB | [2023/27] |
Former [2016/06] | Lock, Graham James Fry Heath & Spence LLP The Gables Massetts Road Horley Surrey RH6 7DQ / GB | Application number, filing date | 14779492.9 | 04.04.2014 | [2016/06] | WO2014US33082 | Priority number, date | US201361808594P | 04.04.2013 Original published format: US 201361808594 P | [2016/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2014165825 | Date: | 09.10.2014 | Language: | EN | [2014/41] | Type: | A2 Application without search report | No.: | EP2981617 | Date: | 10.02.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.10.2014 takes the place of the publication of the European patent application. | [2016/06] | Type: | B1 Patent specification | No.: | EP2981617 | Date: | 05.07.2023 | Language: | EN | [2023/27] | Search report(s) | International search report - published on: | US | 04.12.2014 | (Supplementary) European search report - dispatched on: | EP | 08.12.2016 | Classification | IPC: | C12N15/87, C12N15/00, C12N15/11 | [2016/06] | CPC: |
C12N15/63 (EP,US);
A61P31/00 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C12N15/907 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/06] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | THERAPEUTISCHE VERWENDUNGEN EINER GENOMÄNDERUNG MIT CRISPR-/CAS-SYSTEMEN | [2016/06] | English: | THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/CAS SYSTEMS | [2016/06] | French: | UTILISATIONS THÉRAPEUTIQUES DE L'ÉDITION DE GÉNOME AU MOYEN DE SYSTÈMES CRISPR/CAS | [2016/06] | Entry into regional phase | 04.11.2015 | National basic fee paid | 04.11.2015 | Search fee paid | 04.11.2015 | Designation fee(s) paid | 04.11.2015 | Examination fee paid | Examination procedure | 06.10.2015 | Observations by third parties | 04.11.2015 | Examination requested [2016/06] | 13.07.2017 | Amendment by applicant (claims and/or description) | 02.02.2021 | Despatch of a communication from the examining division (Time limit: M06) | 12.08.2021 | Reply to a communication from the examining division | 29.09.2022 | Cancellation of oral proceeding that was planned for 30.09.2022 | 30.09.2022 | Date of oral proceedings (cancelled) | 09.11.2022 | Communication of intention to grant the patent | 06.03.2023 | Fee for grant paid | 06.03.2023 | Fee for publishing/printing paid | 09.03.2023 | Receipt of the translation of the claim(s) | Divisional application(s) | EP23172496.4 / EP4286517 | Opposition(s) | 08.04.2024 | No opposition filed within time limit [2024/24] | Fees paid | Renewal fee | 27.04.2016 | Renewal fee patent year 03 | 27.04.2017 | Renewal fee patent year 04 | 27.04.2018 | Renewal fee patent year 05 | 29.04.2019 | Renewal fee patent year 06 | 27.04.2020 | Renewal fee patent year 07 | 27.04.2021 | Renewal fee patent year 08 | 27.04.2022 | Renewal fee patent year 09 | 27.04.2023 | Renewal fee patent year 10 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 05.07.2023 | CZ | 05.07.2023 | DK | 05.07.2023 | EE | 05.07.2023 | ES | 05.07.2023 | FI | 05.07.2023 | HR | 05.07.2023 | IT | 05.07.2023 | LT | 05.07.2023 | LV | 05.07.2023 | NL | 05.07.2023 | PL | 05.07.2023 | RO | 05.07.2023 | RS | 05.07.2023 | SE | 05.07.2023 | SI | 05.07.2023 | SK | 05.07.2023 | SM | 05.07.2023 | NO | 05.10.2023 | GR | 06.10.2023 | IS | 05.11.2023 | PT | 06.11.2023 | [2024/36] |
Former [2024/26] | AT | 05.07.2023 | |
CZ | 05.07.2023 | ||
DK | 05.07.2023 | ||
EE | 05.07.2023 | ||
ES | 05.07.2023 | ||
FI | 05.07.2023 | ||
HR | 05.07.2023 | ||
IT | 05.07.2023 | ||
LT | 05.07.2023 | ||
LV | 05.07.2023 | ||
NL | 05.07.2023 | ||
PL | 05.07.2023 | ||
RO | 05.07.2023 | ||
RS | 05.07.2023 | ||
SE | 05.07.2023 | ||
SK | 05.07.2023 | ||
SM | 05.07.2023 | ||
NO | 05.10.2023 | ||
GR | 06.10.2023 | ||
IS | 05.11.2023 | ||
PT | 06.11.2023 | ||
Former [2024/23] | AT | 05.07.2023 | |
CZ | 05.07.2023 | ||
DK | 05.07.2023 | ||
EE | 05.07.2023 | ||
ES | 05.07.2023 | ||
FI | 05.07.2023 | ||
HR | 05.07.2023 | ||
LT | 05.07.2023 | ||
LV | 05.07.2023 | ||
NL | 05.07.2023 | ||
PL | 05.07.2023 | ||
RO | 05.07.2023 | ||
RS | 05.07.2023 | ||
SE | 05.07.2023 | ||
SK | 05.07.2023 | ||
SM | 05.07.2023 | ||
NO | 05.10.2023 | ||
GR | 06.10.2023 | ||
IS | 05.11.2023 | ||
PT | 06.11.2023 | ||
Former [2024/22] | AT | 05.07.2023 | |
CZ | 05.07.2023 | ||
DK | 05.07.2023 | ||
ES | 05.07.2023 | ||
FI | 05.07.2023 | ||
HR | 05.07.2023 | ||
LT | 05.07.2023 | ||
LV | 05.07.2023 | ||
NL | 05.07.2023 | ||
PL | 05.07.2023 | ||
RO | 05.07.2023 | ||
RS | 05.07.2023 | ||
SE | 05.07.2023 | ||
SM | 05.07.2023 | ||
NO | 05.10.2023 | ||
GR | 06.10.2023 | ||
IS | 05.11.2023 | ||
PT | 06.11.2023 | ||
Former [2024/20] | AT | 05.07.2023 | |
ES | 05.07.2023 | ||
FI | 05.07.2023 | ||
HR | 05.07.2023 | ||
LT | 05.07.2023 | ||
LV | 05.07.2023 | ||
NL | 05.07.2023 | ||
PL | 05.07.2023 | ||
RS | 05.07.2023 | ||
SE | 05.07.2023 | ||
SM | 05.07.2023 | ||
NO | 05.10.2023 | ||
GR | 06.10.2023 | ||
IS | 05.11.2023 | ||
PT | 06.11.2023 | ||
Former [2024/10] | AT | 05.07.2023 | |
ES | 05.07.2023 | ||
FI | 05.07.2023 | ||
HR | 05.07.2023 | ||
LT | 05.07.2023 | ||
LV | 05.07.2023 | ||
NL | 05.07.2023 | ||
PL | 05.07.2023 | ||
RS | 05.07.2023 | ||
SE | 05.07.2023 | ||
NO | 05.10.2023 | ||
GR | 06.10.2023 | ||
IS | 05.11.2023 | ||
PT | 06.11.2023 | ||
Former [2024/09] | AT | 05.07.2023 | |
ES | 05.07.2023 | ||
FI | 05.07.2023 | ||
LT | 05.07.2023 | ||
NL | 05.07.2023 | ||
SE | 05.07.2023 | ||
NO | 05.10.2023 | ||
GR | 06.10.2023 | ||
IS | 05.11.2023 | ||
Former [2024/08] | LT | 05.07.2023 | |
NL | 05.07.2023 | ||
NO | 05.10.2023 | ||
GR | 06.10.2023 | ||
Former [2024/05] | NL | 05.07.2023 | Documents cited: | Search | [XYI] - MALI P. ET AL, "RNA-guided human genome engineering via Cas9", SCIENCE, (20130215), vol. 339, no. 6121, doi:10.1126/science.1232033, ISSN 0036-8075, pages 823 - 826, XP055300091 [X] 1,3-10 * the whole document * [Y] 11-14 [I] 2 DOI: http://dx.doi.org/10.1126/science.1232033 | [ ] - P. MALI ET AL, "Supplementary Materials for RNA-Guided Human Genome Engineering via Cas9", SCIENCE, (20130103), vol. 339, no. 6121, doi:10.1126/science.1232033, ISSN 0036-8075, pages 1 - 36, XP055161524 DOI: http://dx.doi.org/10.1126/science.1232033 | [Y] - SEUNG WOO CHO ET AL, "Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease", NATURE BIOTECHNOLOGY, GALE GROUP INC, US, vol. 31, no. 3, doi:10.1038/NBT.2507, ISSN 1087-0156, (20130301), pages 230 - 232, (20130129), XP002699850 [Y] 11 * the whole document * DOI: http://dx.doi.org/10.1038/nbt.2507 | [Y] - CRAIG B. WILEN ET AL, "Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases", PLOS PATHOGENS, (20110401), vol. 7, no. 4, doi:10.1371/journal.ppat.1002020, ISSN 1553-7366, pages e1002020 - e1002020, XP055032912 [Y] 12 * the whole document * DOI: http://dx.doi.org/10.1371/journal.ppat.1002020 | [Y] - BIN SHEN ET AL, "Generation of gene-modified mice via Cas9/RNA-mediated gene targeting", CELL RESEARCH - XIBAO YANJIU, GB, CN, (20130402), vol. 23, no. 5, doi:10.1038/cr.2013.46, ISSN 1001-0602, pages 720 - 723, XP055141533 [Y] 13 * the whole document * DOI: http://dx.doi.org/10.1038/cr.2013.46 | [Y] - MANDAL PANKAJ K ET AL, "Reprogramming human fibroblasts to pluripotency using modified mRNA", NATURE PROTOCOLS, NATURE PUBLISHING GROUP, GB, (20130301), vol. 8, no. 3, doi:10.1038/NPROT.2013.019, ISSN 1750-2799, pages 568 - 582, XP008169776 [Y] 14 * the whole document * DOI: http://dx.doi.org/10.1038/nprot.2013.019 | [A] - SIVAPRAKASH RAMALINGAM ET AL, "A CRISPR way to engineer the human genome", GENOME BIOLOGY, GB, (20130226), vol. 14, no. 2, doi:10.1038/nbt.2508, ISSN 1465-6906, page 107, XP055323697 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1186/gb-2013-14-2-107 | [A] - MARTIN JINEK ET AL, "RNA-programmed genome editing in human cells", ELIFE, GB, (20130129), vol. 2, doi:10.7554/eLife.00471, ISSN 2050-084X, pages e00471 - 1, XP055245475 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.7554/eLife.00471 | [A] - WOONG Y HWANG ET AL, "Efficient genome editing in zebrafish using a CRISPR-Cas system", NATURE BIOTECHNOLOGY, (20130129), vol. 31, no. 3, doi:10.1038/nbt.2501, ISSN 1087-0156, pages 227 - 229, XP055086625 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1038/nbt.2501 | [A] - WENYAN JIANG ET AL, "RNA-guided editing of bacterial genomes using CRISPR-Cas systems", NATURE BIOTECHNOLOGY, US, (20130129), vol. 31, no. 3, doi:10.1038/nbt.2508, ISSN 1087-0156, pages 233 - 239, XP055323877 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1038/nbt.2508 | International search | [Y]US2002106742 (SAMSON MICHEL [FR], et al); | [Y]US2006024819 (FINNEY ROBERT E [US]); | [Y]US2010076057 (SONTHEIMER ERIK J [US], et al); | [Y]US2010093617 (BARRANGOU RODOLPHE [US], et al); | [Y]US2010227805 (KARIN NATHAN [IL], et al); | [Y]US2011262406 (DEL CAMPO JACOB [US], et al); | [Y]US2012192298 (WEINSTEIN EDWARD [US], et al); | [Y] - JINEK ET AL., "A Programmable Dual-RNA?Guided DNA Endonuclease in Adaptive Bacterial Immunity", SCIENCE, (20120817), vol. 337, pages 816 - 821, XP055229606 DOI: http://dx.doi.org/10.1126/science.1225829 | [Y] - CONG ET AL., "Multiplex genome engineering using CRISPR/Cas systems.", SCIENCE, (2013), vol. 339. 612, pages 819 - 823, XP055181424 DOI: http://dx.doi.org/10.1126/science.1229223 | [Y] - HOLT ET AL., "Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.", NATURE BIOTECHNOLOGY, (2010), vol. 28.8, pages 839 - 847, XP055101952 DOI: http://dx.doi.org/10.1038/nbt.1663 | [Y] - RANDAU, LENNART., "RNA processing in the minimal organism Nanoarchaeum equitans.", GENOME BIOL, (2012), vol. 1 3.7, page R63, XP021133987 DOI: http://dx.doi.org/10.1186/gb-2012-13-7-r63 | other | US2009286852 | - CHO S.W. ET AL., "TARGETED GENOME ENGINEERING IN HUMAN CELLS WITH THE CAS9 RNA-GUIDED ENDONUCLEASE", NATURE BIOTECHNOLOGY,, (201303), vol. 31, no. 3, pages 230 - 232, XP002699850 DOI: http://dx.doi.org/10.1038/nbt.2507 | - MALI P. ET AL., "RNA-GUIDED HUMAN GENOME ENGINEERING VIA CAS9", SCIENCE, (20130215), vol. 339, no. 6121, pages 823 - 826, XP055159412 DOI: http://dx.doi.org/10.1126/science.1232033 | - MALI P. ET AL., "SUPPLEMENTARY MATERIALS FOR RNA-GUIDED HUMAN GENOME ENGINEERING VIA CAS9", SCIENCE, (20130103), pages 1 - 36, XP055161524 DOI: http://dx.doi.org/10.1126/science.1232033 | - CONG L. ET AL., "MULTIPLEX GENOME ENGINEERING USING CRISPR/CAS SYSTEMS", SCIENCE, (20130215), vol. 339, no. 6121, pages 819 - 823, XP055067741 DOI: http://dx.doi.org/10.1126/science.1231143 | - CONG L. ET AL., "SUPPLEMENTARY MATERIAL TO : MULTIPLEX GENOME ENGINEERING USING CRISPR/CAS SYSTEMS", SCIENCE, (20120705), XP055067744 DOI: http://dx.doi.org/10.1126/science.1231143 |